Growth Metrics

Pacific Biosciences Of California (PACB) Receivables - Other (2016 - 2017)

Pacific Biosciences Of California has reported Receivables - Other over the past 6 years, most recently at $755000.0 for Q3 2017.

  • For Q3 2017, Receivables - Other changed N/A year-over-year to $755000.0; the TTM value through Sep 2017 reached $755000.0, changed N/A, while the annual FY2016 figure was $5.0 million, 50.0% down from the prior year.
  • Receivables - Other for Q3 2017 was $755000.0 at Pacific Biosciences Of California, roughly flat from $755000.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $10.0 million in Q4 2015 and troughed at $3000.0 in Q4 2013.
  • A 4-year average of $3.4 million and a median of $2.4 million in 2017 define the central range for Receivables - Other.
  • Biggest five-year swings in Receivables - Other: tumbled 99.63% in 2013 and later plummeted 50.0% in 2016.
  • Year by year, Receivables - Other stood at $3000.0 in 2013, then skyrocketed by 333233.33% to $10.0 million in 2015, then plummeted by 50.0% to $5.0 million in 2016, then crashed by 84.9% to $755000.0 in 2017.
  • Business Quant data shows Receivables - Other for PACB at $755000.0 in Q3 2017, $755000.0 in Q2 2017, and $2.4 million in Q1 2017.